Myo-2

N/A

Report date: 2025/06/11 10:41:51
NME

Base Information

Drug NameMyo-2
Drug Alias NameMyo-4
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMitoRx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMitoRx Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A